TABLE 5.
ID | Germline mutations a | Somatic mutations a | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Gene | Type | VAF (%) | AA substitution | Variant annotation b | Gene | Type | VAF (%) | AA substitution | Variant annotation b | Gene classification c | |
1 | BRCA1 | INDEL | 51.4 | p.Leu1679TyrfsTer2 | Pathogenic | IGFN1 | SNV | 17.9 | p.Gly1565Asp | VUS | AML Driver |
NBEAL2 | SNV | 3.1 | p.Leu1093Val | VUS | AML driver | ||||||
TP53 | SNV | 7.2 | p.Cys238Tyr | Pathogenic | AML driver/susceptibility | ||||||
2 | BRCA1 | INDEL | 51.6 | p.Asn363IlefsTer11 | Pathogenic | EPHA4 | SNV | 2.5 | p.Cys191Arg | VUS | Actionable |
TP53 | SNV | 4.8 | p.Cys176Ser | Pathogenic | AML driver/susceptibility | ||||||
3 | NONE | GNA11 | SNV | 3.2 | p.Leu40Phe | Likely pathogenic | Actionable | ||||
4 | BCR | INDEL | 56.8 | p.Lys754AsnfsTer34 | Pathogenic | EPHB2 | SNV | 52.9 | p.Gln626Arg | Likely pathogenic | Actionable |
NOTCH1 | SNV | 40.5 | p.Thr2090Met | VUS | Actionable | ||||||
SLTM | SNV | 52.2 | p.Gln54Arg | Likely pathogenic | Actionable | ||||||
BRCA1 | SNV | 45.3 | p.Arg1495Met | Pathogenic | Susceptibility/actionable | ||||||
5 | NONE | NOTCH1 | SNV | 3.2 | p.Asn104Thr | VUS | Actionable |
Abbreviations: AA, aminoacidic; AML, acute myeloid leukemia; INDEL, insertion/deletion; SNV, single nucleotide variant; VAF, variant allele frequency; VUS, variant of uncertain significance.
Next generation sequencing analysis using custom Myelo panel and the Ion Torrent S5 technology (ThermoFisher).
Annotation of variants for pathogenicity by ClinVar, Varsome, RENOVO.
Gene classification based on our gene lists in the customized Myelo panel; for definitions, see Section 2.3.